Apellis Pharmaceuticals
APLS
#4013
Rank
A$3.44 B
Marketcap
$27.39
Share price
0.09%
Change (1 day)
-63.52%
Change (1 year)

EPS for Apellis Pharmaceuticals (APLS)

EPS in 2023 (TTM): -$7.89

According to Apellis Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$8.21. In 2022 the company made an earnings per share (EPS) of -$9.59 an increase over its 2021 EPS that were of -$13.85.

EPS history for Apellis Pharmaceuticals from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.89-17.75%
2022-$9.59-30.73%
2021-$13.8592.81%
2020-$7.18-11.73%
2019-$8.14123.18%
2018-$3.6527.08%
2017-$2.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.41-58.48%๐Ÿ‡บ๐Ÿ‡ธ USA